Int'l : +1(646) 600-5072 | query@kbvresearch.com
Published Date : 6-Feb-2019 |
Pages: 196 |
Formats: PDF |
The Global Cardiac Pacemaker Market Size is expected to reach $8.0 billion by 2024, globally, rising at a market growth of 6.8% CAGR during the forecast period.
A Cardiac pacemaker is an electrical device and it is used to treat arrhythmias, which leads to irregular heartbeat. Arrhythmia is of two types, tachycardia and bradycardia. Heartbeat, when too fast, is tachycardia and when too slow, it is bradycardia. If the patient suffers from arrhythmia, the heart is weak to pump sufficient blood to the other parts of the body, leading to fatigue and fainting. As per the Disease Control and Prevention (CDC), deaths due to sudden cardiac are reported to be more than 600,000 per year, and almost 50% of patients die during first occurrence of cardiac arrest. The prevalence of atrial and ventricular arrhythmias grows with age and shows no sign of coronary heart disease.
A Cardiac pacemaker is used to help patients suffering from arrhythmias, to lead an active and healthy life style. Pacemaker devices are of two kinds, namely, implantable cardiac pacemaker and external cardiac pacemaker. The implantable pacemaker is placed on the left side of the chest, under the skin, which is guided through a blood vessel to the heart. The external cardiac pacemakers are used in temporary pacing.
Implantable cardiac pacemakers have been witnessing significant demand due to growing cases of slow heart rhythm and cardiac failures. Additionally, technological advancements such as development of MRI compatible pacemakers have further driven the growth of this segment.
Growing Prevalence Of Cardiovascular Disorders
Cardiovascular (CVD) and circulatory diseases have been the leading causes for deaths, globally. The majority of these CVD deaths due to ischemic heart disease (IHD) or cerebrovascular disease. Understanding for CVD and its distribution has become vital for countries to develop national strategies, to reduce the burden of noncommunicable disease (NCD). The focus on NCD prevention and control, globally, was highlighted by the United Nations High Level Meeting on NCDs, in 2011. The member states voluntarily agreed to work towards reducing the risk of premature (defined by the World Health Organization as occurring from ages 30 to 70 years) death from NCDs, including CVD, cancer, chronic lung disease, and diabetes mellitus, by 25% by 2025.
High Cost Of Cardiovascular Treatments
Cardiovascular disease (CVD) has been a major cause for deaths in the United States. Heart attacks or strokes led to deaths in the recent years. CVD is considered to be a costliest chronic disease. Expenses associated with CVD would rise in the coming years. Based on prevalence, death rates, disability and cost, CVD would continue to be the most burdensome disease across the world.
Lack of awareness cardiovascular disorders in the developing nations, expensive treatments and higher product recalls, due to device malfunctioning are the factors that would limit the market expansion during the forecast period. Launching of new devices and development of fast, reliable and cost-effective diagnostic methods would contribute to the market expansion during the forecast period.
The Implantable Cardiac Pacemakers market dominated the Global Cardiac Pacemaker Market by Product 2017, thereby, achieving a market value of $5,019.2 million by 2024, The External Cardiac Pacemaker market is expected to witness highest CAGR of 7.7% during (2018 - 2024).
The North America market would dominate the Global Single-Chamber Cardiac Pacemakers Market by Region 2024 growing at a CAGR of 5.5 % during the forecast period. The Europe market is expected to witness a CAGR of 5.8% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 7.5% during (2018 - 2024).
The North America market dominated the Global Ambulatory Surgery Centers (ASCs) Cardiac Pacemaker Market by Region 2017, growing at a CAGR of 5.7 % during the forecast period. The Europe market is expected to witness a CAGR of 6.1% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 7.7% during (2018 - 2024).
Asia Pacific is the fastest growing region, due to factors such as huge patient population, fast growing economies such as India and China, where the healthcare expenditures have been growing steadily, and rapid growth in the healthcare sector. Additionally, favorable government policies such as relaxation in customs and excise duty are other factors that drive the market growth in the region.
Based on Product, the market is segmented into Implantable Cardiac Pacemakers and External Cardiac Pacemaker. Based on the technology, the market is segmented into Single-Chamber Cardiac Pacemakers, Dual-Chamber Cardiac Pacemakers and Others. Based on End User, the market is segmented into Hospitals; Ambulatory Surgery Centers (ASCs) and Other End User. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The Cardiac Pacemakers market analysis report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories (U.S.), Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co ltd, Cook Medical Group, Medico S.p.A, LivaNova PL, Osypka Medical GmbH, Shree Pacetronix Ltd. and Medline Industries, Inc.
Scope of the Cardiac Pacemakers Market Analysis Report
Market Segmentation:
Implantable Cardiac Pacemakers
External Cardiac Pacemaker
Single-Chamber Cardiac Pacemakers
Dual-Chamber Cardiac Pacemakers
Others
Hospitals
Ambulatory Surgery Centers (ASCs)
Other End User
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Abbott Laboratories (U.S.)
Boston Scientific Corporation
Biotronik SE & Co. KG
Lepu Medical Technology Co ltd
Cook Medical Group
Medico S.p.A
LivaNova PL
Osypka Medical GmbH
Shree Pacetronix Ltd.
Medline Industries, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cardiac Pacemaker Market, by Product
1.4.2 Global Cardiac Pacemaker Market, by Technology
1.4.3 Global Cardiac Pacemaker Market, by End User
1.4.4 Global Cardiac Pacemaker Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.1.3 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Cardiac Pacemaker Market by Product
3.1.1 Global Implantable Cardiac Pacemakers Market by Region
3.1.2 Global External Cardiac Pacemaker Market by Region
Chapter 4. Global Cardiac Pacemaker Market by Technology
4.1.1 Global Single-Chamber Cardiac Pacemakers Market by Region
4.1.2 Global Dual-Chamber Cardiac Pacemakers Market by Region
4.1.3 Global Other Technology Cardiac Pacemaker Market by Region
Chapter 5. Global Cardiac Pacemaker Market by End User
5.1.1 Global Hospitals Cardiac Pacemaker Market by Region
5.1.2 Global Ambulatory Surgery Centers (ASCs) Cardiac Pacemaker Market by Region
5.1.3 Global Other End User Cardiac Pacemaker Market by Region
Chapter 6. Global Cardiac Pacemaker Market by Region
6.1 North America Cardiac Pacemaker Market
6.1.1 North America Cardiac Pacemaker Market by Product
6.1.1.1 North America Implantable Cardiac Pacemakers Market by Country
6.1.1.2 North America External Cardiac Pacemaker Market by Country
6.1.2 North America Cardiac Pacemaker Market by Technology
6.1.2.1 North America Single-Chamber Cardiac Pacemakers Market by Country
6.1.2.2 North America Dual-Chamber Cardiac Pacemakers Market by Country
6.1.2.3 North America Other Technology Cardiac Pacemaker Market by Country
6.1.3 North America Cardiac Pacemaker Market by End User
6.1.3.1 North America Hospitals Cardiac Pacemaker Market by Country
6.1.3.2 North America Ambulatory Surgery Centers (ASCs) Cardiac Pacemaker Market by Country
6.1.3.3 North America Other End User Cardiac Pacemaker Market by Country
6.1.4 North America Cardiac Pacemaker Market by Country
6.1.4.1 US Cardiac Pacemaker Market
6.1.4.1.1 US Cardiac Pacemaker Market by Product
6.1.4.1.2 US Cardiac Pacemaker Market by Technology
6.1.4.1.3 US Cardiac Pacemaker Market by End User
6.1.4.2 Canada Cardiac Pacemaker Market
6.1.4.2.1 Canada Cardiac Pacemaker Market by Product
6.1.4.2.2 Canada Cardiac Pacemaker Market by Technology
6.1.4.2.3 Canada Cardiac Pacemaker Market by End User
6.1.4.3 Mexico Cardiac Pacemaker Market
6.1.4.3.1 Mexico Cardiac Pacemaker Market by Product
6.1.4.3.2 Mexico Cardiac Pacemaker Market by Technology
6.1.4.3.3 Mexico Cardiac Pacemaker Market by End User
6.1.4.4 Rest of North America Cardiac Pacemaker Market
6.1.4.4.1 Rest of North America Cardiac Pacemaker Market by Product
6.1.4.4.2 Rest of North America Cardiac Pacemaker Market by Technology
6.1.4.4.3 Rest of North America Cardiac Pacemaker Market by End User
6.2 Europe Cardiac Pacemaker Market
6.2.1 Europe Cardiac Pacemaker Market by Product
6.2.1.1 Europe Implantable Cardiac Pacemakers Market by Country
6.2.1.2 Europe External Cardiac Pacemaker Market by Country
6.2.2 Europe Cardiac Pacemaker Market by Technology
6.2.2.1 Europe Single-Chamber Cardiac Pacemakers Market by Country
6.2.2.2 Europe Dual-Chamber Cardiac Pacemakers Market by Country
6.2.2.3 Europe Other Technology Cardiac Pacemaker Market by Country
6.2.3 Europe Cardiac Pacemaker Market by End User
6.2.3.1 Europe Hospitals Cardiac Pacemaker Market by Country
6.2.3.2 Europe Ambulatory Surgery Centers (ASCs) Cardiac Pacemaker Market by Country
6.2.3.3 Europe Other End User Cardiac Pacemaker Market by Country
6.2.4 Europe Cardiac Pacemaker Market by Country
6.2.4.1 Germany Cardiac Pacemaker Market
6.2.4.1.1 Germany Cardiac Pacemaker Market by Product
6.2.4.1.2 Germany Cardiac Pacemaker Market by Technology
6.2.4.1.3 Germany Cardiac Pacemaker Market by End User
6.2.4.2 UK Cardiac Pacemaker Market
6.2.4.2.1 UK Cardiac Pacemaker Market by Product
6.2.4.2.2 UK Cardiac Pacemaker Market by Technology
6.2.4.2.3 UK Cardiac Pacemaker Market by End User
6.2.4.3 France Cardiac Pacemaker Market
6.2.4.3.1 France Cardiac Pacemaker Market by Product
6.2.4.3.2 France Cardiac Pacemaker Market by Technology
6.2.4.3.3 France Cardiac Pacemaker Market by End User
6.2.4.4 Russia Cardiac Pacemaker Market
6.2.4.4.1 Russia Cardiac Pacemaker Market by Product
6.2.4.4.2 Russia Cardiac Pacemaker Market by Technology
6.2.4.4.3 Russia Cardiac Pacemaker Market by End User
6.2.4.5 Spain Cardiac Pacemaker Market
6.2.4.5.1 Spain Cardiac Pacemaker Market by Product
6.2.4.5.2 Spain Cardiac Pacemaker Market by Technology
6.2.4.5.3 Spain Cardiac Pacemaker Market by End User
6.2.4.6 Italy Cardiac Pacemaker Market
6.2.4.6.1 Italy Cardiac Pacemaker Market by Product
6.2.4.6.2 Italy Cardiac Pacemaker Market by Technology
6.2.4.6.3 Italy Cardiac Pacemaker Market by End User
6.2.4.7 Rest of Europe Cardiac Pacemaker Market
6.2.4.7.1 Rest of Europe Cardiac Pacemaker Market by Product
6.2.4.7.2 Rest of Europe Cardiac Pacemaker Market by Technology
6.2.4.7.3 Rest of Europe Cardiac Pacemaker Market by End User
6.3 Asia Pacific Cardiac Pacemaker Market
6.3.1 Asia Pacific Cardiac Pacemaker Market by Product
6.3.1.1 Asia Pacific Implantable Cardiac Pacemakers Market by Country
6.3.1.2 Asia Pacific External Cardiac Pacemaker Market by Country
6.3.2 Asia Pacific Cardiac Pacemaker Market by Technology
6.3.2.1 Asia Pacific Single-Chamber Cardiac Pacemakers Market by Country
6.3.2.2 Asia Pacific Dual-Chamber Cardiac Pacemakers Market by Country
6.3.2.3 Asia Pacific Other Technology Cardiac Pacemaker Market by Country
6.3.3 Asia Pacific Cardiac Pacemaker Market by End User
6.3.3.1 Asia Pacific Hospitals Cardiac Pacemaker Market by Country
6.3.3.2 Asia Pacific Ambulatory Surgery Centers (ASCs) Cardiac Pacemaker Market by Country
6.3.3.3 Asia Pacific Other End User Cardiac Pacemaker Market by Country
6.3.4 Asia Pacific Cardiac Pacemaker Market by Country
6.3.4.1 China Cardiac Pacemaker Market
6.3.4.1.1 China Cardiac Pacemaker Market by Product
6.3.4.1.2 China Cardiac Pacemaker Market by Technology
6.3.4.1.3 China Cardiac Pacemaker Market by End User
6.3.4.2 Japan Cardiac Pacemaker Market
6.3.4.2.1 Japan Cardiac Pacemaker Market by Product
6.3.4.2.2 Japan Cardiac Pacemaker Market by Technology
6.3.4.2.3 Japan Cardiac Pacemaker Market by End User
6.3.4.3 India Cardiac Pacemaker Market
6.3.4.3.1 India Cardiac Pacemaker Market by Product
6.3.4.3.2 India Cardiac Pacemaker Market by Technology
6.3.4.3.3 India Cardiac Pacemaker Market by End User
6.3.4.4 South Korea Cardiac Pacemaker Market
6.3.4.4.1 South Korea Cardiac Pacemaker Market by Product
6.3.4.4.2 South Korea Cardiac Pacemaker Market by Technology
6.3.4.4.3 South Korea Cardiac Pacemaker Market by End User
6.3.4.5 Singapore Cardiac Pacemaker Market
6.3.4.5.1 Singapore Cardiac Pacemaker Market by Product
6.3.4.5.2 Singapore Cardiac Pacemaker Market by Technology
6.3.4.5.3 Singapore Cardiac Pacemaker Market by End User
6.3.4.6 Malaysia Cardiac Pacemaker Market
6.3.4.6.1 Malaysia Cardiac Pacemaker Market by Product
6.3.4.6.2 Malaysia Cardiac Pacemaker Market by Technology
6.3.4.6.3 Malaysia Cardiac Pacemaker Market by End User
6.3.4.7 Rest of Asia Pacific Cardiac Pacemaker Market
6.3.4.7.1 Rest of Asia Pacific Cardiac Pacemaker Market by Product
6.3.4.7.2 Rest of Asia Pacific Cardiac Pacemaker Market by Technology
6.3.4.7.3 Rest of Asia Pacific Cardiac Pacemaker Market by End User
6.4 LAMEA Cardiac Pacemaker Market
6.4.1 LAMEA Cardiac Pacemaker Market by Product
6.4.1.1 LAMEA Implantable Cardiac Pacemakers Market by Country
6.4.1.2 LAMEA External Cardiac Pacemaker Market by Country
6.4.2 LAMEA Cardiac Pacemaker Market by Technology
6.4.2.1 LAMEA Single-Chamber Cardiac Pacemakers Market by Country
6.4.2.2 LAMEA Dual-Chamber Cardiac Pacemakers Market by Country
6.4.2.3 LAMEA Other Technology Cardiac Pacemaker Market by Country
6.4.3 LAMEA Cardiac Pacemaker Market by End User
6.4.3.1 LAMEA Hospitals Cardiac Pacemaker Market by Country
6.4.3.2 LAMEA Ambulatory Surgery Centers (ASCs) Cardiac Pacemaker Market by Country
6.4.3.3 LAMEA Other End User Cardiac Pacemaker Market by Country
6.4.4 LAMEA Cardiac Pacemaker Market by Country
6.4.4.1 Brazil Cardiac Pacemaker Market
6.4.4.1.1 Brazil Cardiac Pacemaker Market by Product
6.4.4.1.2 Brazil Cardiac Pacemaker Market by Technology
6.4.4.1.3 Brazil Cardiac Pacemaker Market by End User
6.4.4.2 Argentina Cardiac Pacemaker Market
6.4.4.2.1 Argentina Cardiac Pacemaker Market by Product
6.4.4.2.2 Argentina Cardiac Pacemaker Market by Technology
6.4.4.2.3 Argentina Cardiac Pacemaker Market by End User
6.4.4.3 UAE Cardiac Pacemaker Market
6.4.4.3.1 UAE Cardiac Pacemaker Market by Product
6.4.4.3.2 UAE Cardiac Pacemaker Market by Technology
6.4.4.3.3 UAE Cardiac Pacemaker Market by End User
6.4.4.4 Saudi Arabia Cardiac Pacemaker Market
6.4.4.4.1 Saudi Arabia Cardiac Pacemaker Market by Product
6.4.4.4.2 Saudi Arabia Cardiac Pacemaker Market by Technology
6.4.4.4.3 Saudi Arabia Cardiac Pacemaker Market by End User
6.4.4.5 South Africa Cardiac Pacemaker Market
6.4.4.5.1 South Africa Cardiac Pacemaker Market by Product
6.4.4.5.2 South Africa Cardiac Pacemaker Market by Technology
6.4.4.5.3 South Africa Cardiac Pacemaker Market by End User
6.4.4.6 Nigeria Cardiac Pacemaker Market
6.4.4.6.1 Nigeria Cardiac Pacemaker Market by Product
6.4.4.6.2 Nigeria Cardiac Pacemaker Market by Technology
6.4.4.6.3 Nigeria Cardiac Pacemaker Market by End User
6.4.4.7 Rest of LAMEA Cardiac Pacemaker Market
6.4.4.7.1 Rest of LAMEA Cardiac Pacemaker Market by Product
6.4.4.7.2 Rest of LAMEA Cardiac Pacemaker Market by Technology
6.4.4.7.3 Rest of LAMEA Cardiac Pacemaker Market by End User
Chapter 7. Company Profiles
7.1 Medtronic Plc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisitions:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisitions:
7.3 Boston Scientific Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expense
7.4 BIOTRONIK SE & CO. KG
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Product Launch:
7.5 Cook Group Incorporated (Cook Medical Inc.)
7.5.1 Company Overview
7.6 LivaNova PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental & Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition:
7.7 Ospyka Medical
7.7.1 Company Overview
7.8 Medico S.p.A
7.8.1 Company Overview
7.9 Zoll Medical Corporation (Asahi Kasei Group Company)
7.9.1 Company Overview